Navigation Links
Robotic device appears useful for surgical removal of cancer involving the tonsils

A new robotic surgery technique appears promising for the removal of cancer involving the tonsil region, according to a report in the December issue of Archives of OtolaryngologyHead & Neck Surgery, one of the JAMA/Archives journals.

Typically, surgeons trying to remove tonsils of patients with cancer through the mouth have limited access to the area, according to background information in the article. If the cancer has spread to any of the surrounding tissues, an open approach involving cutting through the skin is needed. These procedures take a long time, can cause long-term difficulty swallowing and usually require the placement of a tracheotomy tube.

Gregory S. Weinstein, M.D., and colleagues at the University of Pennsylvania, Philadelphia, evaluated the feasibility of a new surgical techniquetransoral robotic surgery (TORS)on 27 participants undergoing radical tonsillectomy for cancer between May 2005 and April 2007. The surgical system consists of a console, where the surgeon sits at a distance from the patient; a surgical cart; three instrument-holding arms and a central arm with an endoscope. This lighted optical instrument with two video cameras offers a three-dimensional view of the inside of the body. The surgical arms are controlled by the surgeons movement of handles in the console. In TORS, the mouth is held open and incisions are made in the gums, soft palate, tongue and throat muscles to reach and remove the tonsils and any surrounding cancerous tissue.

The surgeons successfully performed TORS in all cases, the authors write. All robotic arms functioned optimally during the procedures, and no interference between robotic arms was noted. In 25 patients (93 percent), surgeons were able to remove all cancerous tissues. The average length of surgery was one hour and 43 minutes. Following the procedure, 26 out of the 27 patients were swallowing without the use of a stomach tube.

No deaths occurred, and although complications occurred in five of the 27 patients (19 percent), most were resolved without significant consequences. The early complication rate is comparable to the rates reported for the alternative therapies of non-robotic transoral surgery, open surgical resection and concurrent chemoradiation treatments, the authors write. Complicationsincluding death, pneumonia or fistula (an opening or passage in the skin or organs)that are usually reported during these other types of procedures did not occur in the TORS patients.

Radical tonsillectomy using TORS is a new technique that offers excellent access for resection of carcinomas of the tonsil with acceptable acute morbidity, or complications, they conclude. Future reports will focus on long-term oncologic and functional outcomes.


Contact: Marc Kaplan
JAMA and Archives Journals

Related medicine news :

1. St. Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders
2. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
3. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
4. Robotics lab helps stroke patients with recovery
5. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
6. MSU engineering team designs innovative medical device
7. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
8. Implantable device designed to detect, stop seizures under study at MCG
9. Visiprise Launches Podcast Series with AMR to Support Medical Device Manufacturers
10. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
11. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
Post Your Comments:
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: